Details of the Drug Reposition

General Information of This Drug (ID: DMNSC0O)

Drug Name
DNL747   DMNSC0O
Drug Type
Small molecular drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Alzheimer disease DISF8S70 8A20 Phase 1 [1]
Amyotrophic lateral sclerosis DISF7HVM 8B60.0 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03757325) Study to Evaluate DNL747 in Subjects With Alzheimer's Disease. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03757351) Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis. U.S. National Institutes of Health.